Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize tumor killing effect of an anti-VISTA monoclonal antibody in tumor bearing mice

被引：1
|
作者：
Jiang, Xiling
Leu, Jocelyn
Singh, Indrajeet
Snyder, Linda A.
Wang, Weirong
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-2085
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2085
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PHARMACOKINETIC STUDY OF RADIOLABELED ANTI-COLORECTAL CARCINOMA MONOCLONAL-ANTIBODIES IN TUMOR-BEARING NUDE-MICE
    DOUILLARD, JY
    CHATAL, JF
    SACCAVINI, JC
    CURTET, C
    KREMER, M
    PEUVREL, P
    KOPROWSKI, H
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1985, 11 (04): : 107 - 113
  • [22] Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in Mice
    Reig-Lopez, Javier
    Maldonado, Maria del Mar
    Merino-Sanjuan, Matilde
    Cruz-Collazo, Ailed M.
    Ruiz-Calderon, Jean F.
    Mangas-Sanjuan, Victor
    Dharmawardhane, Suranganie
    Duconge, Jorge
    PHARMACEUTICS, 2020, 12 (10) : 1 - 17
  • [23] Efficacy and concentration-response of murine anti-VEGF monoclonal antibody in tumor-bearing mice and extrapolation to humans
    Mordenti, J
    Thomsen, K
    Licko, V
    Chen, H
    Meng, YG
    Ferrara, N
    TOXICOLOGIC PATHOLOGY, 1999, 27 (01) : 14 - 21
  • [24] Monoclonal anti-EGFreceptor antibody (ior-R3) pharmacokinetic study in tumor bearing nude mice:: Role of the receptor-mediated endocytosis on drug clearance
    Duconge, J
    Fernández-Sánchez, E
    Macías, A
    Castillo, R
    Garcia, I
    Beausoleil, I
    Amador, JF
    Matheu, J
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2002, 27 (02) : 101 - 105
  • [25] Anti-tumor Effect of Sinapine on S180-bearing Mice and Its Mechanism of Action
    Ke Mu-Gen
    Wu Guo-Xin
    Wu Sheng-Xi
    Huang Lu-Qiang
    Nan Shu-Lei
    PROCEEDINGS OF 2009 INTERNATIONAL CONFERENCE OF NATURAL PRODUCT AND TRADITIONAL MEDICINE, VOLS 1 AND 2, 2009, : 603 - 609
  • [26] Monoclonal anti-EGFreceptor antibody (ior-R3) pharmacokinetic study in tumor bearing nude mice: Role of the receptor-mediated endocytosis on drug clearance
    J. Duconge
    E. Fernández-Sánchez
    A. Macías
    R. Castillo
    I. Garcia
    I. Beausoleil
    J. F. Amador
    J. Matheu
    European Journal of Drug Metabolism and Pharmacokinetics, 2002, 27 : 101 - 105
  • [27] ANTI-TUMOR EFFECT OF ACTINOMYCIN-D ENTRAPPED IN LIPOSOMES BEARING SUBUNITS OF TUMOR-SPECIFIC MONOCLONAL IMMUNOGLOBULIN-M ANTIBODY
    HASHIMOTO, Y
    SUGAWARA, M
    MASUKO, T
    HOJO, H
    CANCER RESEARCH, 1983, 43 (11) : 5328 - 5334
  • [28] Mechanism-Based Competitive Binding Model to Investigate the Effect of Neonatal Fc Receptor Binding Affinity on the Pharmacokinetic of Humanized Anti-VEGF Monoclonal IgG1 Antibody in Cynomolgus Monkey
    Chee M. Ng
    Paul J. Fielder
    Jin Jin
    Rong Deng
    The AAPS Journal, 2016, 18 : 948 - 959
  • [29] EFFECT OF ACETYLATION ON MONOCLONAL-ANTIBODY ZCE-025 FAB' - DISTRIBUTION IN NORMAL AND TUMOR-BEARING MICE
    TARBURTON, JP
    HALPERN, SE
    HAGAN, PL
    SUDORA, E
    CHEN, A
    FRIDMAN, DM
    PFAFF, AE
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1990, 9 (02): : 221 - 230
  • [30] Mechanism-Based Competitive Binding Model to Investigate the Effect of Neonatal Fc Receptor Binding Affinity on the Pharmacokinetic of Humanized Anti-VEGF Monoclonal IgG1 Antibody in Cynomolgus Monkey
    Ng, Chee M.
    Fielder, Paul J.
    Jin, Jin
    Deng, Rong
    AAPS JOURNAL, 2016, 18 (04): : 948 - 959
12345